Edap Tms S.a. (EDAP) Stock Score, Valuation & Financial Research
Edap Tms S.a. is in the Healthcare sector and Medical - Specialties industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 17/100.
Quick answer for EDAP
Edap Tms S.a. currently has a Wall Street Score of 17/100. The stored market price is $4.76. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Edap Tms S.a. does
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithot
EDAP financial snapshot
- Wall Street Score:
- 17/100
- Current price:
- $4.76
- Market capitalization:
- $178.2M
- Revenue:
- $62.9M
- Net income:
- $-38.9M
- Free cash flow:
- $-22.2M
- Cash:
- $11.8M
- Total debt:
- $41.7M
- EPS:
- -1.01
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 10/100
What stands out
- Reported year-over-year revenue growth is -0.1%.
- Free cash flow is $-22.2M, showing cash burn in the current stored period.
- The balance sheet shows $11.8M of cash versus $41.7M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research EDAP
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.